Advertisement
Australia markets close in 1 hour 50 minutes
  • ALL ORDS

    7,810.20
    -88.70 (-1.12%)
     
  • ASX 200

    7,560.40
    -81.70 (-1.07%)
     
  • AUD/USD

    0.6399
    -0.0026 (-0.41%)
     
  • OIL

    84.83
    +2.10 (+2.54%)
     
  • GOLD

    2,404.50
    +6.50 (+0.27%)
     
  • Bitcoin AUD

    97,441.99
    +745.96 (+0.77%)
     
  • CMC Crypto 200

    1,286.39
    +400.85 (+44.02%)
     
  • AUD/EUR

    0.6013
    -0.0018 (-0.29%)
     
  • AUD/NZD

    1.0874
    -0.0001 (-0.01%)
     
  • NZX 50

    11,748.66
    -87.38 (-0.74%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,877.05
    +29.06 (+0.37%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,837.40
    +67.38 (+0.38%)
     
  • Hang Seng

    16,184.02
    -201.85 (-1.23%)
     
  • NIKKEI 225

    37,189.98
    -889.72 (-2.34%)
     

Is Anavex Life Sciences a Smart Stock to Buy Now?

Is Anavex Life Sciences a Smart Stock to Buy Now?

Shares of clinical-stage biotechnology company Anavex Life Sciences (NASDAQ: AVXL) recently shot higher. Investors reacting to great news for its Alzheimer's disease drug candidate, blarcamesine, drove the stock about 40% higher when the market opened on Friday, Dec. 2. Is Anavex Life Sciences a smart stock to buy now, or will the road ahead be a rocky one full of potholes?